Global CyberKnife Market Size Study, By Application (Tumor, Cancer, Vascular Malformation), By End-use (Hospitals, Outpatient Facilities, Research & Manufacturing), and Regional Forecasts 2022-2032

Description

The Global CyberKnife Market is valued at approximately USD 542.01 million in 2023 and is expected to expand at a compound annual growth rate (CAGR) of 17.6% during the forecast period 2024-2032. CyberKnife, an advanced robotic radiosurgery system, is revolutionizing cancer treatment by providing non-invasive, highly precise radiation therapy for various conditions, including tumors, vascular malformations, and other critical medical conditions. The growing preference for non-surgical alternatives to conventional tumor removal procedures has fueled market growth, alongside continuous technological advancements enhancing the precision and efficiency of CyberKnife systems.

The increasing global prevalence of cancer remains a primary driver of the CyberKnife market. Factors such as rising tobacco and alcohol consumption, sedentary lifestyles, and increasing exposure to environmental carcinogens contribute significantly to the surge in cancer cases worldwide. Additionally, heightened awareness about early-stage cancer detection and treatment, coupled with the rising demand for personalized and targeted therapies, has led to greater adoption of CyberKnife technology in hospitals and outpatient facilities.

The non-invasive nature of CyberKnife treatment offers several advantages, including minimal recovery time, reduced trauma, and lower hospital admissions, making it a highly preferred alternative to traditional surgical interventions. Additionally, the integration of artificial intelligence (AI) and robotics into radiation therapy is significantly enhancing treatment accuracy and optimizing radiation dosage to reduce collateral damage to healthy tissues. New product launches, such as the CyberKnife S7 FIM Robotic Radio Surgery System, are further accelerating market growth by offering enhanced operational efficiency and treatment flexibility.

Geographically, North America dominates the market, driven by a high prevalence of chronic diseases, advanced healthcare infrastructure, and strong government investments in cancer treatment technologies. The United States accounts for a significant share due to the presence of leading radiation oncology centers, favorable reimbursement policies, and increased adoption of outpatient cancer treatment modalities. Meanwhile, Europe and the Asia-Pacific regions are witnessing substantial growth, with increasing healthcare investments, growing awareness about non-invasive cancer treatments, and improvements in radiation therapy accessibility. The Latin American market is also emerging as a high-growth region, driven by rising cancer incidence rates and expanding healthcare infrastructure in countries such as Brazil and Argentina.

Major Market Players Included in this Report:

Accuray Incorporated
Koninklijke Philips
Advanced Micro Devices
AiCure
Arm Limited
Atomwise, Inc.
Ayasdi AI LLC
Baidu, Inc.
Clarifai, Inc.
Cyrcadia Health
Enlitic, Inc.
Varian Medical Systems
Siemens Healthineers
Elekta AB
ViewRay, Inc.

The Detailed Segments and Sub-Segments of the Market are Explained Below:

By Application:

Tumor
Cancer
Vascular Malformation
Others

By End-use:

Hospitals
Outpatient Facilities
Research & Manufacturing

By Region:

North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Rest of Europe
Asia Pacific
China
India
Japan
Australia
South Korea
Thailand
Rest of Asia Pacific
Latin America
Brazil
Argentina
Rest of Latin America
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
Rest of Middle East & Africa

Years Considered for the Study:

Historical Year - 2022
Base Year - 2023
Forecast Period - 2024 to 2032

Key Takeaways:

Market Estimates & Forecast for 10 years from 2022 to 2032
Annualized revenues and regional-level analysis for each market segment
Competitive landscape with information on major players in the market
Analysis of key business strategies and recommendations for future market approach
Demand-side and supply-side analysis of the market

Chapter 1. Global CyberKnife Market Executive Summary

1.1. Global CyberKnife Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
- 1.3.1. By Application
- 1.3.2. By End Use
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendations & Conclusion

Chapter 2. Global CyberKnife Market Definition and Research Assumptions

2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
- 2.3.1. Inclusion & Exclusion
- 2.3.2. Limitations
- 2.3.3. Supply Side Analysis
  - 2.3.3.1. Availability
  - 2.3.3.2. Infrastructure
  - 2.3.3.3. Regulatory Environment
  - 2.3.3.4. Market Competition
  - 2.3.3.5. Economic Viability (Consumer's Perspective)
- 2.3.4. Demand Side Analysis
  - 2.3.4.1. Regulatory Frameworks
  - 2.3.4.2. Technological Advancements
  - 2.3.4.3. Environmental Considerations
  - 2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates

Chapter 3. Global CyberKnife Market Dynamics

3.1. Market Drivers
- 3.1.1. Rising prevalence of cancer and vascular malformations
- 3.1.2. Growing demand for non-invasive and minimally invasive treatment options
- 3.1.3. Technological advancements in CyberKnife systems
3.2. Market Challenges
- 3.2.1. High costs of CyberKnife systems and treatments
- 3.2.2. Reimbursement complexities for advanced radiation therapies
3.3. Market Opportunities
- 3.3.1. Increasing adoption of AI and robotics in radiation therapy
- 3.3.2. Expansion of outpatient facilities for advanced radiotherapy

Chapter 4. Global CyberKnife Market Industry Analysis

4.1. Porter's Five Forces Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.1.6. Futuristic Approach to Porter's Five Forces Model
- 4.1.7. Porter's Five Forces Impact Analysis
4.2. PESTEL Analysis
- 4.2.1. Political
- 4.2.2. Economic
- 4.2.3. Social
- 4.2.4. Technological
- 4.2.5. Environmental
- 4.2.6. Legal
4.3. Top Investment Opportunity
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendations & Conclusion

Chapter 5. Global CyberKnife Market Size & Forecasts by Application 2022-2032

5.1. Segment Dashboard
5.2. Global CyberKnife Market: Application Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
- 5.2.1. Tumor
- 5.2.2. Cancer
- 5.2.3. Vascular Malformation
- 5.2.4. Others

Chapter 6. Global CyberKnife Market Size & Forecasts by End Use 2022-2032

6.1. Segment Dashboard
6.2. Global CyberKnife Market: End Use Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
- 6.2.1. Hospitals
- 6.2.2. Outpatient Facilities
- 6.2.3. Research & Manufacturing

Chapter 7. Global CyberKnife Market Size & Forecasts by Region 2022-2032

7.1. North America CyberKnife Market
- 7.1.1. U.S. CyberKnife Market
  - 7.1.1.1. Application Breakdown Size & Forecasts, 2022-2032
  - 7.1.1.2. End Use Breakdown Size & Forecasts, 2022-2032
- 7.1.2. Canada CyberKnife Market
- 7.1.3. Mexico CyberKnife Market
7.2. Europe CyberKnife Market
- 7.2.1. UK CyberKnife Market
- 7.2.2. Germany CyberKnife Market
- 7.2.3. France CyberKnife Market
- 7.2.4. Italy CyberKnife Market
- 7.2.5. Spain CyberKnife Market
- 7.2.6. Denmark CyberKnife Market
- 7.2.7. Sweden CyberKnife Market
- 7.2.8. Norway CyberKnife Market
- 7.2.9. Rest of Europe CyberKnife Market
7.3. Asia-Pacific CyberKnife Market
- 7.3.1. China CyberKnife Market
- 7.3.2. Japan CyberKnife Market
- 7.3.3. India CyberKnife Market
- 7.3.4. Australia CyberKnife Market
- 7.3.5. South Korea CyberKnife Market
- 7.3.6. Thailand CyberKnife Market
- 7.3.7. Rest of Asia Pacific CyberKnife Market
7.4. Latin America CyberKnife Market
- 7.4.1. Brazil CyberKnife Market
- 7.4.2. Argentina CyberKnife Market
- 7.4.3. Rest of Latin America CyberKnife Market
7.5. Middle East & Africa CyberKnife Market
- 7.5.1. South Africa CyberKnife Market
- 7.5.2. Saudi Arabia CyberKnife Market
- 7.5.3. UAE CyberKnife Market
- 7.5.4. Kuwait CyberKnife Market
- 7.5.5. Rest of Middle East & Africa CyberKnife Market

Chapter 8. Competitive Intelligence

8.1. Key Company SWOT Analysis
- 8.1.1. Advanced Micro Devices
- 8.1.2. AiCure
- 8.1.3. Arm Limited
8.2. Top Market Strategies
8.3. Company Profiles
- 8.3.1. Accuray Incorporated
- 8.3.2. Koninklijke Philips
- 8.3.3. Atomwise, Inc.
- 8.3.4. Ayasdi AI LLC
- 8.3.5. Baidu, Inc.
- 8.3.6. Clarifai, Inc.
- 8.3.7. Cyrcadia Health
- 8.3.8. Enlitic, Inc.

Chapter 9. Research Process

9.1. Research Process
- 9.1.1. Data Mining
- 9.1.2. Analysis
- 9.1.3. Market Estimation
- 9.1.4. Validation
- 9.1.5. Publishing
9.2. Research Attributes